企業プロフィール
Sanara MedTech 株価・ニュース・カタリスト
- ティッカー:
- SMTI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
34.00 USD (-0.44%)
終値
最終更新: 2026年8月17日
195M USD
時価総額
株価変動の要因
As of Aug 17, 2026, SMTI closed down 0.44% at $34.00. No new same-company headline was identified in the current news window.
企業概要
Surgical Wound and Tissue Repair
Sanara MedTech develops and commercializes products intended to improve surgical healing and reduce complications and healthcare costs.
Soft-Tissue Repair Portfolio
The company’s products address wound cleansing, infection management, extracellular matrix support, and tissue repair across surgical specialties.
Procedure-Based Commercial Model
Sanara sells through hospital and surgeon relationships, with revenue driven by procedure volumes, product adoption, and expansion of its direct commercial organization.
Technology Acquisition Strategy
The company supplements internal development with licensed and acquired technologies that can be distributed through its existing surgical channel.
今後のカタリスト
- Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care. It is a steady operating story, so the market will focus on adoption and margin discipline.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。